Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR604 in Congenital Coagulation Factor VII Deficiency
NCT07711158Phase 2Not yet recruiting
- Sponsor
- Shanghai RAAS
- Start
- Jul 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 2 trial of SR604 in Congenital Coagulation Factor VII Deficiency, sponsored by Shanghai RAAS. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
SR604
03
Conditions
Congenital Coagulation Factor VII Deficiency
Beyond the preview
Go deeper on NCT07711158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07711158.